2021-01-06,Y-mAbs Therapeutics to Present At 39th Annual J.P. Morgan Healthcare Conference
2020-12-28,Y-mAbs Announces Sale of Priority Review Voucher
2020-12-18,Y-mAbs Signs License Agreement with SciClone for DANYELZA® (naxitamab-gqgk) and Omburtamab in China
2020-12-18,Y-mAbs Signs Distribution Agreement with Swixx for DANYELZA® (naxitamab-gqgk) and Omburtamab in Eastern Europe
2020-12-16,Y-mAbs Announces Pipeline Update
2020-12-10,Is YMAB A Good Stock To Buy Now?
2020-12-09,Y-mAbs Announces Update on DANYELZA® (naxitamab-gqgk) at ESMO
2020-12-07,"Y-mAbs to Host Virtual Research & Development Day on Wednesday, December 16"
2020-12-04,Insider Sells Y-mAbs Therapeutics Stock
2020-12-04,Y-mAbs and Takeda Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) and Omburtamab in Israel
2020-11-25,FDA Approves Y-mAbs DANYELZA® (naxitamab-gqgk) for the Treatment of Neuroblastoma
2020-11-19,Y-mAbs Announces Update on Omburtamab in DIPG
2020-11-06,"YmAbs Therapeutics, Inc. (YMAB) Q3 2020 Earnings Call Transcript"
2020-11-05,Y-mAbs Announces Third Quarter 2020 Financial Results and Recent Corporate Developments
2020-10-29,"Y-mAbs to Announce Third Quarter 2020 Financial and Operating Results on November 5, 2020"
2020-10-28,We're Not Very Worried About Y-mAbs Therapeutics' (NASDAQ:YMAB) Cash Burn Rate
2020-10-26,Y-mAbs Announces FDA Clearance of IND for Lutetium-177 Labeled Omburtamab Antibody for Adult Indications
2020-10-16,Y-mAbs Announces Update on Naxitamab and Omburtamab in Neuroblastoma
2020-10-14,Y-mAbs Announces FDA Clearance of IND for its Lutetium-177 Labeled Omburtamab Antibody
2020-10-09,"Bragar Eagel & Squire, P.C. Is Investigating Evolus, Lizhi, Iovance Biotherapeutics, and Y-mAbs Therapeutics and Encourages Investors to Contact the Firm"
2020-10-08,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Y-mAbs Therapeutics, Inc. - YMAB"
2020-10-08,"Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Y-mAbs Therapeutics, Inc. (YMAB) Investigation"
2020-10-07,Y-mAbs Nivatrotamab for the Treatment of Patients with Neuroblastoma Granted Orphan Drug Designation and Rare Pediatric Disease Designation by FDA
2020-10-06,"The Daily Biotech Pulse: Pfizer, BioNTech Begin European Filing For Coronavirus Vaccine, Y-mAbs BLA Rejected, GlycoMimetics Granted Rare Pediatric Disease Designation"
2020-10-05,Y-mAbs Provides Regulatory Update on Omburtamab for the Treatment of Patients with Neuroblastoma
2020-08-06,Y-mAbs Announces Second Quarter 2020 Financial Results and Recent Corporate Developments
2020-08-06,Y-mAbs Announces Completion of Submission of Omburtamab Biologics License Application to FDA
2020-08-04,"Y-mAbs to Announce Second Quarter 2020 Financial and Operating Results on August 6, 2020"
2020-07-27,Y-mAbs Announces Data to be Presented at 2020 SIOP
2020-07-14,Y-mAbs Announces Update on SADA Technology and New Preclinical SADA Construct
2020-07-05,"Y-mAbs Therapeutics, Inc. (YMAB): Are Hedge Funds Right About This Stock?"
2020-06-30,Y-mAbs Announces Initiation of Submission of Omburtamab Rolling Biologics License Application to the FDA
2020-06-02,Y-mAbs Announces U.S. FDA Acceptance of Biologics License Application for Danyelza (naxitamab) for the Treatment of Neuroblastoma for Priority Review
2020-05-22,Should You Own This Sleeper Biotech Stock?
2020-05-13,Y-mAbs Announces Data to be Presented at 2020 ASCO Annual Meeting
2020-05-11,H.C. Wainwright Sticks to Their Buy Rating for Y-Mabs Therapeutics Inc
2020-05-09,"YmAbs Therapeutics, Inc. (YMAB) Q1 2020 Earnings Call Transcript"
2020-05-07,Y-mAbs Announces First Quarter 2020 Financial Results and Recent Corporate Developments
2020-05-07,"Was The Smart Money Right About Y-mAbs Therapeutics, Inc. (YMAB)?"
2020-04-30,"UPDATE - Y-mAbs to Announce First Quarter 2020 Financial and Operating Results on May 7, 2020"
2020-04-30,"Y-mAbs to Announce 2019 Financial and Operating Results on May 7, 2020"
2020-04-28,We Think Y-mAbs Therapeutics (NASDAQ:YMAB) Can Afford To Drive Business Growth
2020-04-24,Y-mAbs Announces Appointment of Laura J. Hamill to its Board of Directors
2020-04-15,Y-mAbs enters into Worldwide Exclusive License Agreement for SADA Technology  a Novel Radioimmunotherapy Platform
2020-04-01,Y-mAbs Announces Submission of Naxitamab Biologics License Application to U.S. FDA
2020-03-12,Y-mAbs Announces 2019 Financial Results and Recent Corporate Developments
2020-03-12,"Y-mAbs Therapeutics, Inc. to Host Earnings Call"
2020-03-05,"Y-mAbs to Announce 2019 Financial and Operating Results on March 12, 2020"
2020-02-26,Y-mAbs Announces Positive Pre-BLA Meeting with FDA for Omburtamab
2020-01-07,Y-mAbs Therapeutics To Present At 38th Annual J.P. Morgan Healthcare Conference
2019-12-24,"Benzinga Pro's Top 5 Stocks To Watch For Tues., Dec. 24, 2019: TSLA, WCC, ACST, YMAB, ITCI"
2019-12-16,"Is Y-mAbs Therapeutics, Inc. (YMAB) A Good Stock To Buy?"
2019-12-12,Y-mAbs GD2-GD3 Vaccine Granted Rare Pediatric Disease Designation
2019-12-11,Y-mAbs Announces Positive Naxitamab Frontline Data
2019-12-05,Y-mAbs and the European Medicines Agency Pediatric Committee Reach Agreement on the Pediatric Investigation Plan for Omburtamab
2019-12-05,"Y-mAbs to Host R&D Event and Live Webcast on Wednesday, December 11"
2019-11-29,Y-mAbs Initiates Rolling Submission of Biologics License Application to U.S. FDA for Naxitamab for Treatment of Neuroblastoma
2019-11-15,Y-mAbs Announces Update on Omburtamab in DSRCT
2019-11-13,Y-mAbs Announces Third Quarter 2019 Financial Results and Recent Corporate Developments
2019-11-06,Y-mAbs to Announce Third Quarter 2019 Financial and Operating Results on November 13
2019-11-01,Y-mAbs Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares
2019-11-01,"Y-mAbs Flags Potential Delay In Pre-BLA Meeting, Sticks To Regulatory Filing Timeline"
2019-10-30,"Heres What Hedge Funds Think About Y-mAbs Therapeutics, Inc. (YMAB)"
2019-10-29,Y-mAbs Announces Pricing of Public Offering of Common Stock
2019-10-29,Y-mAbs Announces Proposed Public Offering of Common Stock
2019-10-29,"The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study"
2019-10-28,We're Not Very Worried About Y-mAbs Therapeutics's (NASDAQ:YMAB) Cash Burn Rate
2019-10-28,Y-mAbs Announces Positive Omburtamab Clinical Data
2019-10-25,Y-mAbs Announces Naxitamab Update
2019-09-04,Wedbush: Y-mAbs Could Attract Investor Attention As Market Volatility Grows
2019-08-30,Y-mAbs Announces Data to be Presented at 2019 CTOS
2019-08-14,"YmAbs Therapeutics, Inc. (YMAB) Q2 2019 Earnings Call Transcript"
2019-08-14,Y-mAbs Announces Second Quarter 2019 Financial Results and Recent Corporate Developments
2019-08-08,"How Much Of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Do Insiders Own?"
2019-08-07,Y-mAbs to Announce Second Quarter 2019 Financial and Operating Results on August 14
2019-07-08,Y-mAbs Announces Successful Pre-BLA Meeting with FDA for Naxitamab
2019-07-01,Y-mAbs Announces Recruitment Status for Pivotal Trials
2019-07-01,Y-mAbs Secures Commercial Radiolabeling Capacity
2019-06-26,Y-mAbs Announces Data to be Presented at 2019 SIOP
2019-05-15,Y-mAbs Announces Data to be Presented at 2019 ASCO Annual Meeting
2019-05-14,Y-mAbs Announces Development Update on Cancer Vaccine Program
2019-05-10,Y-mAbs Announces First Quarter 2019 Financial Results and Recent Corporate Developments
2019-05-08,Y-mAbs Therapeutics To Present at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas
2019-05-07,"Heres What Hedge Funds Think About Y-mAbs Therapeutics, Inc. (YMAB)"
2019-04-03,Y-mAbs Therapeutics To Present At The H.C. Wainwright Global Life Sciences Conference in London
2019-03-30,"Have Insiders Been Buying Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Shares?"
2019-03-22,Y-mAbs Announces 2018 Financial Results and Corporate Development Highlights
2019-03-08,Y-mAbs Therapeutics To Present At Cowens 39th Annual Health Care Conference
2019-02-13,Y-mAbs Therapeutics to Present at PEGS Boston
2018-12-20,"What Kind Of Investor Owns Most Of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB)?"
2018-12-13,Y-mAbs Therapeutics To Present At 37th Annual J.P. Morgan Healthcare Conference
2018-12-11,Y-mAbs Announces Appointment of Gérard Ber to its Board of Directors and Planned Departure of Michael Buschle
2018-12-10,Y-mAbs Therapeutics Announces FDA Clearance of IND for its Bispecific GD2 Antibody
2018-11-13,Y-mAbs Announces Third Quarter 2018 Financial Results and Recent Corporate Developments
2018-11-01,Bispecific GD2 Antibody In Vivo Data to be Presented at ASH
2018-10-23,Naxitamab Receives Positive Opinion for Orphan Medicinal Product Designation Approval in the EU
2018-09-25,Y-mAbs Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares
2018-09-21,Y-mAbs' stock soars above IPO price in its public debut
2018-09-21,Pediatric cancer biotech Y-mAbs Therapeutics raises $96 million in IPO
2018-09-21,[$$] Y-mAbs Therapeutics Sells Extra Shares in IPO
